Skip to content

Clinical trials

Lambert-Eaton Myasthenic Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lambert-Eaton Myasthenic Syndrome Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20101
20111
20121
20141
20161
20211
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
No longer available5
Approved for marketing3
Recruiting3
Unknown status2
Enrolling by invitation2
Withdrawn1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Catalyst Pharmaceuticals, Inc.3
LMU Klinikum2
Addario Lung Cancer Medical Institute1
Ain Shams University1
Centre Hospitalier Universitaire de Liege1
David Lacomis, MD1
David P. Richman, MD1
FDA Office of Orphan Products Development1
Fred Hutchinson Cancer Center1
Heinrich-Heine University, Duesseldorf1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lambert-Eaton Myasthenic Syndrome22
Myasthenia Gravis7
Muscular Atrophy, Spinal4
Muscular Dystrophy, Facioscapulohumeral4
Myasthenic Syndromes, Congenital4
Neuromuscular Diseases4
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating4
Friedreich Ataxia3
Glycogen Storage Disease Type II3
Myositis, Inclusion Body3

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.